Officials lift pause on Johnson & Johnson COVID-19 vaccine
Federal officials said that the United States should resume use of the Johnson & Johnson COVID-19 vaccine, which has been on pause since April 13th. The Food and Drug Administration and Centers for Disease Control and Prevention had instituted the pause after receiving reports of unusual blood clots in a handful of people who received the shot.
The decision follows the recommendation of an independent CDC advisory group, which recommended Friday that the vaccine be used for all adults. The committee stressed that officials should make people aware of the risk of rare blood clots, which appear most often in women under 50.
As of Friday, officials had 15 reports of women developing rare blood clots called cerebral venous sinus thrombosis…